LVM Capital Management’s AstraZeneca AZN Stock Holding History

LVM Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$703K	Hold	3,705	–	–	0.06%	96
2026 Q1	$731K	Sell	3,705 -1	-0%	-$193	0.07%	89
2025 Q4	$681K	Hold	3,706	–	–	0.06%	91
2025 Q3	$569K	Hold	3,706	–	–	0.05%	106
2025 Q2	$518K	Hold	3,706	–	–	0.05%	111
2025 Q1	$545K	Hold	3,706	–	–	0.06%	103
2024 Q4	$486K	Buy	3,706 +56	+2%	+$7.84K	0.05%	114
2024 Q3	$569K	Hold	3,650	–	–	0.06%	105
2024 Q2	$569K	Hold	3,650	–	–	0.06%	105
2024 Q1	$495K	Hold	3,650	–	–	0.06%	105
2023 Q4	$492K	Hold	3,650	–	–	0.06%	107
2023 Q3	$494K	Hold	3,650	–	–	0.07%	98
2023 Q2	$522K	Sell	3,650 -125	-3%	-$18.4K	0.07%	96
2023 Q1	$524K	Hold	3,775	–	–	0.07%	93
2022 Q4	$512K	Hold	3,775	–	–	0.07%	91
2022 Q3	$414K	Buy	3,775 +125	+3%	+$15.9K	0.06%	95
2022 Q2	$482K	Hold	3,650	–	–	0.07%	91
2022 Q1	$484K	Hold	3,650	–	–	0.06%	96
2021 Q4	$425K	Hold	3,650	–	–	0.06%	93
2021 Q3	$438K	Hold	3,650	–	–	0.07%	89
2021 Q2	$437K	Hold	3,650	–	–	0.07%	88
2021 Q1	$363K	Hold	3,650	–	–	0.06%	89
2020 Q4	$365K	Sell	3,650 -100	-3%	-$10.6K	0.06%	87
2020 Q3	$411K	Hold	3,750	–	–	0.08%	75
2020 Q2	$397K	Hold	3,750	–	–	0.08%	73
2020 Q1	$335K	Hold	3,750	–	–	0.08%	76
2019 Q4	$374K	Hold	3,750	–	–	0.07%	84
2019 Q3	$334K	Hold	3,750	–	–	0.07%	85
2019 Q2	$310K	Hold	3,750	–	–	0.07%	88
2019 Q1	$303K	Hold	3,750	–	–	0.07%	89
2018 Q4	$285K	Sell	3,750 -650	-15%	-$50.8K	0.07%	87
2018 Q3	$348K	Hold	4,400	–	–	0.08%	88
2018 Q2	$309K	Hold	4,400	–	–	0.07%	91
2018 Q1	$308K	Hold	4,400	–	–	0.07%	87
2017 Q4	$305K	Hold	4,400	–	–	0.07%	90
2017 Q3	$298K	Hold	4,400	–	–	0.07%	89
2017 Q2	$300K	Sell	4,400 -500	-10%	-$32.7K	0.08%	89
2017 Q1	$305K	Buy	4,900 +500	+11%	+$29.1K	0.08%	89
2016 Q4	$240K	Buy	4,400 +1,100	+33%	+$62.5K	0.07%	99
2016 Q3	$490K	Sell	3,300 -1,800	-35%	-$118K	0.16%	64
2016 Q2	$308K	Sell	5,100 -100	-2%	-$5.81K	0.09%	85
2016 Q1	$293K	Hold	5,200	–	–	0.09%	86
2015 Q4	$353K	Sell	5,200 -2,054	-28%	-$135K	0.12%	72
2015 Q3	$462K	Sell	7,254 -160	-2%	-$10.5K	0.17%	67
2015 Q2	$472K	Sell	7,414 -1,786	-19%	-$122K	0.16%	66
2015 Q1	$630K	Sell	9,200 -100	-1%	-$6.95K	0.21%	59
2014 Q4	$655K	Buy	9,300 +2,700	+41%	+$193K	0.22%	56
2014 Q3	$472K	Hold	6,600	–	–	0.16%	68
2014 Q2	$490K	Sell	6,600 -400	-6%	-$28.9K	0.16%	64
2014 Q1	$454K	Hold	7,000	–	–	0.16%	66
2013 Q4	$416K	Sell	7,000 -3,000	-30%	-$163K	0.15%	75
2013 Q3	$519K	Hold	10,000	–	–	0.2%	61
2013 Q2	$473K	Buy	+10,000	New	+$509K	0.19%	64

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ISS

Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

LVM Capital Management's AZN Position: Q2 2026 in Review

LVM Capital Management held its AstraZeneca (AZN) position steady in Q2 2026 at 3,705 shares worth $703K. The position accounts for 0.06% of the portfolio, ranked #96.

LVM Capital Management first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $731K in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

LVM Capital Management held 3,705 shares of AstraZeneca worth $703K as of Q2 2026.
LVM Capital Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.06% of LVM Capital Management's portfolio in Q2 2026, its #96 holding.
LVM Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
LVM Capital Management's AstraZeneca position peaked at $731K in Q1 2026.
655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on LVM Capital Management's 13F filing for Q2 2026, filed 9 Jul 2026.